Religare Health Insurance Pre IPO (Review & Analysis)

05 July, 2021

Religare Health Insurance Pre IPO (Review & Analysis) | Religare Unlisted Shares Price | Planify

Discover and get info Religare Health Insurance Unlisted Pre IPO Stock before buying, selling or investing - Complete Review, Analysis, Products, Strengths, Financials & Valuations, Promoters, latest News and estimated returns.

Religare Health Insurance company Limited was incorporated in July2012 headquartered in Gurugram Haryana. Religare Health Insurance is marketed by a team behind the hospital chain known as Fortis HealthCare which is one of the six standalone health insurers in India.

One of the biggest strengths of Religare Health Insurance is a Strong brand name with diversified products and services and providing almost all kind of Health Insurance. Religare Health Insurance has a strong network and connection with more than 5420 leading hospitals across the country.

The company has shown a profit of 0.48 Cr in quarterly earnings of June 2019 against loss of 1.2 Crore in the last quarter of June 2018 which is a good sign. However, income from investment also increased from 48,352 thousand in 2018 to 51,211 thousand in 2019.

Religare Enterprises Limited is a major stakeholder with 88.46% of the company’s Share means a strong Backup. The company has tied up with more than 10,000 hospitals and does not involve any third party in claim settlement. At, planify we would rate this company 3 out of 5.

Please check out the link mentioned below to read the planify view in Financial Express over Religare Health Insurance.   

Check the complete Research Report on Religare Health Insurance and keep yourself updated on latest News on Religare Health Insurance at:

For more information Contact us at:
+91 706 55 60002
+91 706 55 60011,
or e-mail us at

Click here to subscribe to our YouTube Channel & Get More Stock Market Investment Tips:

Our Services:
-Investment Banking
-Pitch deck & Fund Raising for Start-ups
-Life, Health, Car & General Insurance